Gene injection tested to ease debilitating diabetic pain
NCT ID NCT01002235
Summary
This early-stage study tested the safety of a new gene therapy called Engensis (VM202) for people with painful nerve damage caused by diabetes. Twelve participants received injections in their leg muscles to see if the treatment was safe and if it could reduce their chronic pain. The main goal was to check for side effects, while also measuring any changes in pain levels over a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diablo Clinical Research Hospital
Walnut Creek, California, 94598, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.